AstraZeneca (NASDAQ:AZN) reported quarterly earnings results on February 10, 2026 that fell short of analyst expectations. The Healthcare company reported earnings per share of…
AstraZeneca (NASDAQ:AZN) reported quarterly earnings results on February 10, 2026 that fell short of analyst expectations.
The Healthcare company reported earnings per share of $2.12, missing the consensus estimate of $2.18 by $0.06 per share. Revenue came in at $15.5B, missing the estimate of $15.6B.
AstraZeneca's stock moved following the earnings release. The stock currently trades at $199.48 with a market capitalization of $279.9B.
Current market data
NASDAQ · AZN
$165.98
Up: +$1.49 · +0.91%
Live quote updated
Our Markets Team monitors market data, SEC filings, analyst actions, earnings releases, and corporate announcements to produce timely updates for investors.
Keep reading
institutional ·
institutional ·
dividends ·
institutional ·
